Time and Location:
8 – 9 November 2023 | Amsterdam, Netherlands
Meet us in Amsterdam, engage with our speakers face to face about China QPPV requirements and practices, and get real-time feedback for your questions.
The DIA Global QPPV Forum is a must-attend conference for anyone involved in pharmacovigilance. With a focus squarely on the most critical issues in today’s industry, tackling global QPPV challenges, trends demanding heightened QPPV awareness, and the transformative impact of modern technology. Plus, it will continue the ever-popular ‘QPPV Talks,’ offering quick, inspirational insights drawn from real-world cases.
Expect valuable insights from regulatory authorities and international industry leaders, ensuring this conference addresses the pressing issues that QPPVs face today. Mark your calendar for the ‘Hot Topics’ session, a not-to-be-missed highlight!
Join us at the DIA Global QPPV Forum to network with your peers, gain valuable insights, and stay ahead in this constantly evolving role.
Proudly presented by Accestra, an in-field expert in the pharmaceutical and pharmacovigilance industry, we look forward to sharing our expertise on ‘China QPPV.’ Don’t miss this unparalleled opportunity to elevate your understanding and stay ahead of the curve.
9th November 2023, 9:00 – 10:30 AM (CET time)
Location: Mercure Hotel Amsterdam City
Address: Joan Muyskenweg 10, 1096 CJ Amsterdam, Netherlands
Demystifying China’s RPPV/QPPV Landscape
- Regulatory Framework of China Pharmacovigilance
- Overview of China RPPV/QPPV
- China RPPV vs EU QPPV
- Authority Inspection Key Points
- Tips and Regulations Overview
Marylene Zhan, Senior PV Manager at Accestra Consulting
Ms. Marylene Zhan is a senior consultant at Accestra Consulting with extensive experience in pharmacovigilance and regulatory affairs. With a Master’s Degree from the Zhongnan University of Economics and Law. Marylene is a seasoned bilingual and bicultural consultant who specializes in China regulatory compliance and pharmacovigilance services (RA/PV). She has a wealth of knowledge on Chinese Pharmaceutical regulations and in-depth insight into dealing with Chinese market access requirements. Marylene has a rich experience in serving international pharma companies with market entry into China, providing support in the areas of adverse event monitoring and reporting, literature screening, PV agreements, Chinese GVP and local regulations, SOP & PSMF writing, and more.